Understanding how HIV-1 starts the process of copying its genetic material
Structural understanding of the HIV-1 reverse transcription initiation process
This study is looking at how the HIV virus starts to make copies of itself, focusing on how it interacts with certain molecules in our bodies, and it hopes to find new ways to stop the virus from spreading.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Harvard University NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project ID | NIH-10891642 on NIH RePORTER |
What this research studies
This research investigates the initial steps of HIV-1 reverse transcription, which is crucial for the virus to replicate. It focuses on the structural interactions between the viral genome and host tRNA, revealing how two molecules of reverse transcriptase (RT) work together to initiate this process accurately. By using advanced techniques like cryo-electron microscopy, the study aims to uncover the complex architecture that governs this critical phase of HIV replication. This understanding could lead to new strategies for disrupting the virus's lifecycle.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV who are seeking new treatment options.
Not a fit: Patients who are not infected with HIV or those who have already achieved viral suppression may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to novel therapeutic approaches that effectively inhibit HIV replication.
How similar studies have performed: Other research has shown success in understanding viral replication mechanisms, suggesting that this approach may yield valuable insights.
Where this research is happening
Cambridge, United States
- Harvard University — Cambridge, United States (Active)
Researchers
- Principal investigator: D'souza, Victoria Manuel — Harvard University
- Study coordinator: D'souza, Victoria Manuel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.